| Symbol | CIZZF |
|---|---|
| Name | CIZZLE BIOTECHNOLOGY HLDGS PLC. |
| Sector | UNDEFINED |
| Region | Europe |
| Industry | - |
| Address | EC3V 0HR United Kingdom ENG 6th Floor 60, Gracechurch Street |
| Telephone | +44 0 20 3934 6630 |
| Fax | — |
| — | |
| Website | https://cizzlebiotechnology.com/ |
| Incorporation | GB |
| Incorporated On | 2007 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | — |
| Audit Status | AUDITED |
| Reporting Status | International Reporting: LSE - London Stock Exchange |
| CIK | — |
| Description | Cizzle Biotechnology Holdings Plc, together with its subsidiaries, operates as a cancer diagnostics company in the United Kingdom. It develops a non-invasive blood test for early lung cancer detection using CIZ1B biomarker technology. Additional info from OTC: |
No news found.